{"product_id":"astranahealth-five-forces-analysis","title":"Astrana Health Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eElevate Your Analysis with the Complete Porter's Five Forces Analysis\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eAstrana Health faces nuanced competitive pressures—from concentrated suppliers and savvy payers to emerging digital care substitutes—and this snapshot highlights key tension points shaping its strategy. Ready for deeper, data-driven force ratings, visuals, and actionable implications? Unlock the full Porter's Five Forces Analysis to inform investment and strategic decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialist and hospital leverage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eHigh-demand specialists and hospital systems exert negotiating leverage as AAMC projects a US physician shortfall of up to 124,000 by 2034, concentrating bargaining power in tertiary and niche subspecialties. Astrana’s dependence on tertiary access increases supplier power, but steering volume across its network and using diversified contracts and tiered networks mitigates concentration risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrimary care network dependence\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePCPs are central to Astrana’s coordinated-care model, so retention and recruitment are critical; over 6,300 primary care HPSAs existed in 2024 (HRSA), giving local groups leverage on economics. Astrana offsets this with panel-management tools, shared-savings arrangements and physician enablement services, and long-term alignment through value contracts lowers churn risk over time.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnology and data vendors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEHR, analytics, and interoperability vendors can create high switching costs as ONC reports certified EHR use exceeds 90% in hospitals and the 21st Century Cures Act (2020) enforces API\/data portability requirements; Astrana’s scale enables multi-vendor mixes and internal tooling to cut vendor dependence. Contract clauses for data portability and FHIR APIs reduce lock-in, but healthcare cyberthreats and HIPAA\/compliance obligations slow vendor substitution.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAncillary and post-acute providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAncillary and post-acute partners—diagnostics, home health, SNFs, and rehab—shape total cost-of-care pathways by driving downstream utilization and facility-based episode costs; SNF occupancy was roughly 70% in 2024, tightening local capacity and pricing. Local market concentration can raise prices or narrow access windows, while Astrana’s preferred networks and value-based contracts recapture leverage. Utilization management and outcome benchmarks force suppliers to compete on measurable value and episode efficiency.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDiagnostics: influence imaging and lab episode costs\u003c\/li\u003e\n\u003cli\u003eHome health: rising role in shifting care out of facilities\u003c\/li\u003e\n\u003cli\u003eSNF\/rehab: 2024 SNF occupancy ~70%—capacity-driven pricing\u003c\/li\u003e\n\u003cli\u003ePreferred networks\/VBAs: recapture dollars via risk-sharing\u003c\/li\u003e\n\u003cli\u003eBenchmarks: utilization\/outcomes drive supplier competition\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharma and device ecosystem\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eDrug and device costs are largely set upstream, limiting Astrana’s direct price control. Formularies, prior authorization and clinical pathways temper spend; PBMs manage roughly 80% of U.S. prescriptions (2024), concentrating supplier power. Partnerships with PBMs and payers align incentives to lower net cost through rebates and risk-sharing. Outcomes-based protocols shift focus to effectiveness over list price.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eUpstream pricing limits Astrana’s list-price control\u003c\/li\u003e\n\u003cli\u003eFormularies\/PAs\/care pathways restrain utilization\u003c\/li\u003e\n\u003cli\u003ePBM\/payer deals (~80% PBM claim share, 2024) lower net cost\u003c\/li\u003e\n\u003cli\u003eOutcomes-based contracts prioritize effectiveness\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialist shortages, PBM\/EHR lock-in heighten supplier-concentration risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAstrana faces concentrated supplier power in high-demand specialists (AAMC projects US physician shortfall up to 124,000 by 2034) and local tertiary markets, mitigated by network steering and tiered contracts. Primary care leverage exists with \u0026gt;6,300 HPSAs in 2024, offset by value contracts and panel tools. Tech and PBM lock-in (EHR use \u0026gt;90% hospitals; PBMs ~80% script share, 2024) raise switching costs but data-portability clauses reduce risk.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSupplier\u003c\/th\u003e\n\u003cth\u003eKey 2024\/Proj. Metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpecialists\u003c\/td\u003e\n\u003ctd\u003ePhysician shortfall up to 124,000 by 2034\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrimary care\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;6,300 HPSAs (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTech\u003c\/td\u003e\n\u003ctd\u003eEHR use \u0026gt;90% hospitals (ONC)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePBMs\u003c\/td\u003e\n\u003ctd\u003e~80% prescription share (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSNF\u003c\/td\u003e\n\u003ctd\u003eOccupancy ~70% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eUncovers key drivers of competition, customer influence, and market entry risks specific to Astrana Health, highlighting supplier power, buyer leverage, and substitutes. Evaluates control held by suppliers and buyers, barriers deterring new entrants, and disruptive threats that could reshape Astrana Health’s pricing power and profitability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA clear, one-sheet Porter's Five Forces summary for Astrana Health that instantly highlights competitive pain points and strategic levers; customize pressure levels or swap in your own data for scenario testing. Clean, slide-ready layout with optional spider chart—no macros, easy to integrate into dashboards or reports.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePayers set reimbursement terms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePayers—Medicare Advantage (now over 30 million enrollees in 2024), Medicaid managed care (covering roughly 70% of beneficiaries), and large commercial plans—wield strong leverage over rates and risk delegation. Star ratings and quality metrics directly affect MA bonuses and contract economics, while statutory MLR floors of 80\/85% constrain pricing. Astrana must deliver measurable outcomes to protect margins, and multi-payer diversification reduces single-buyer dependence.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment program influence\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCMS policies on risk adjustment, benchmark rates and quality bonuses (MA QBP up to 5%) directly move revenue; with Medicare Advantage enrollment topping about 31 million in 2024, benchmarks and coding shifts have material impact. Rapid regulatory changes can reprice contracts in quarters, but Astrana’s compliance and quality infrastructure buffers shocks, and diversified participation across MA and ACO-like models spreads policy risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEmployer and broker channels\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eLarge employers and brokers steer plan design and referral, indirectly shaping Astrana’s volumes; employer-sponsored coverage totaled about 156 million people in the US in 2023, making these channels pivotal. They demand broad networks and cost guarantees, with self-funded buyers pushing for downside protection. Astrana’s win rate depends on demonstrable total-cost savings—programs showing 5–15% reductions—and transparent reporting of utilization and outcomes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePatient choice and experience\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003ePatients can switch PCPs and plans annually, driving churn risk; 2024 surveys indicate roughly half of consumers consider switching for better access and digital tools. Access, convenience, care coordination and same-day visits raise retention and perceived value. Strong NPS and word-of-mouth amplify buyer power across local markets.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eChurn risk: annual switching\u003c\/li\u003e\n\u003cli\u003eRetention drivers: access, digital tools\u003c\/li\u003e\n\u003cli\u003eValue enhancers: coordination, same-day\u003c\/li\u003e\n\u003cli\u003eAmplifier: NPS\/word-of-mouth\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eData transparency expectations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003ePayers demand granular, timely quality and utilization data; in 2024 over 11 million Medicare beneficiaries are aligned in ACOs, increasing reporting scrutiny. Missing SLA-driven reports weakens Astrana’s bargaining position and can trigger payment adjustments. Astrana’s analytics and peer benchmarking above market norms materially strengthens renewal leverage.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eReporting SLA adherence: critical\u003c\/li\u003e\n\u003cli\u003eAnalytics = negotiation asset\u003c\/li\u003e\n\u003cli\u003eBenchmarking improves renewal leverage\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePayers, Employers, Patients: MA benchmarks, MLR floors and \u003cstrong\u003e5-15%\u003c\/strong\u003e TCO wins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePayers (MA ~31M in 2024; Medicaid MCOs cover ~70%) drive rates via benchmarks, MLR floors (80\/85%) and quality bonuses. Employers (156M covered in 2023) and brokers demand networks and 5–15% TCO savings; proven outcomes increase win rates. Patient churn (~50% willing to switch for access\/digital) makes access, coordination, analytics and SLA adherence critical negotiation assets.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024 Value\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMA enrollment\u003c\/td\u003e\n\u003ctd\u003e~31,000,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEmployer coverage\u003c\/td\u003e\n\u003ctd\u003e156,000,000 (2023)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMLR\u003c\/td\u003e\n\u003ctd\u003e80\/85%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePatient switch intent\u003c\/td\u003e\n\u003ctd\u003e~50%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eAstrana Health Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact Porter's Five Forces analysis for Astrana Health you'll receive upon purchase—no placeholders or samples. The document is the fully formatted, final file and is ready for immediate download and use. It contains the complete competitive assessment, insights, and implications. Purchase grants instant access to this identical deliverable.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":56163162718585,"sku":"astranahealth-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/astranahealth-five-forces-analysis.png?v=1762715648","url":"https:\/\/portersfiveforce.com\/products\/astranahealth-five-forces-analysis","provider":"Porter's Five Forces","version":"1.0","type":"link"}